The Prostate Cancer UK Clinical Champions Programme is a magic key that helps open doors to opportunities and achievements that would not otherwise have been possible.
Meet our Champions
Clinical Champions Cohort 1
Clinical Champions Cohort 2
Clinical Champions Cohort 3
What does the programme involve?
We’ve partnered with Living Potential, an innovative leadership development organisation to support us deliver our sector-leading Clinical Champions Programme. Our programme will support and inspire you to drive meaningful improvements for people living with or at risk of prostate cancer.
As part of the programme you will receive:
Training on change leadership, system leadership, improvement science and implementing an improvement project.
Virtual improvement group meetings that allow time to connect with peers.
Individual support around your improvement ambitions and leadership development.
Opportunities to meet and network with inspiring leaders.
Being the only nurse on the cohort was a daunting thought but going ahead was the best thing I’ve done. The programme has been an enlightening experience in terms of recognising your value and what leadership skills you already have and reflecting on and developing those.
Who is the programme for?
We know all roles across the prostate cancer pathway are critical to transforming care, that’s why we actively recruit a multi-disciplinary group to this programme. The programme is open to passionate and inspiring professionals who are driven to improve prostate cancer care.
We encourage applications from all those working with men with prostate cancer including those who might not traditionally be viewed as part of the core MDT such as nurses, primary care professionals and AHPs.
We'll be opening for recruitment in winter 2024.
If you have any specific queries about the Clinical Champions Programme or want to get in touch with one of our Champions about the work they are doing, please contact the Improvement Programmes Team.
Our Prostate Cancer UK Improvement Programmes are partly funded by grants from Astellas Pharma Ltd, Bayer UK and Roche Products Ltd. However, none of these organisations have any influence over the educational content of the programmes.